Efficacy and Safety of BGB-290 in the Treatment of Metastatic HER2-Negative Breast Cancer Patients With BRCA Mutation in China

Cancer Hospital Chinese Academy of Medical Sciences, Beijing

Liaoning Cancer Hospital and Institute, Shenyang

The First Hospital of Jilin University, Changchun

The Second Hospital of Jilin University, Changchun

Harbin Medical University Cancer Hospital, Harbin

Fudan University Shanghai Cancer Center, Shanghai

Jiangsu Province Cancer Hospital, Nanjing

Jiangsu Province Hospital, Nanjing

Tianjin Medical University Cancer Institute and Hospital, Tianjin

Zhejiang University College of Medicine Second Affiliated Hospital, Hangzhou

Zhejiang Cancer Hospital, Hangzhou

Fujian Medical University Union Hospital, Fuzhou

Xiangya Hospital of Central South University, Changsha

Hunan Cancer Hospital, Changsha

Zhongnan Hospital of Wuhan University Wuhan, Wuhan

Henan Cancer Hospital, Zhengzhou

Sun Yat Sen Memorial Hospital, Sun Yat Sen University (North), Guangzhou

Sun Yat Sen University Cancer Center, Guangzhou

West China Hospital, Sichuan University, Chengdu

Sichuan Academy of Medical Sciences and Sichuan Provincial Peoples Hospital, Chengdu